CIMETIDINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
When do Cimetidine Hydrochloride patents expire, and when can generic versions of Cimetidine Hydrochloride launch?
Cimetidine Hydrochloride is a drug marketed by Dava Pharms Inc, Hospira, Luitpold, Teva Parenteral, Vintage Pharms Llc, Ani Pharms, Chartwell Molecular, Cycle, G And W Labs Inc, Pai Holdings Pharm, Pharm Assoc, and Pharmobedient Cnsltg. and is included in twenty-one NDAs.
The generic ingredient in CIMETIDINE HYDROCHLORIDE is cimetidine hydrochloride. There are twenty-five drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cimetidine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CIMETIDINE HYDROCHLORIDE?
- What are the global sales for CIMETIDINE HYDROCHLORIDE?
- What is Average Wholesale Price for CIMETIDINE HYDROCHLORIDE?
Summary for CIMETIDINE HYDROCHLORIDE
US Patents: | 0 |
Applicants: | 12 |
NDAs: | 21 |
Finished Product Suppliers / Packagers: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 65 |
Patent Applications: | 794 |
Formulation / Manufacturing: | see details |
DailyMed Link: | CIMETIDINE HYDROCHLORIDE at DailyMed |
![CIMETIDINE HYDROCHLORIDE drug patent expirations Drug patent expirations by year for CIMETIDINE HYDROCHLORIDE](/p/graph/s/t/CIMETIDINE_HYDROCHLORIDE-patent-expirations.png)
Recent Clinical Trials for CIMETIDINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Phase 4 |
University of Washington | Phase 4 |
Wollo University | Phase 4 |
Pharmacology for CIMETIDINE HYDROCHLORIDE
Drug Class | Histamine-2 Receptor Antagonist |
Mechanism of Action | Histamine H2 Receptor Antagonists |
Anatomical Therapeutic Chemical (ATC) Classes for CIMETIDINE HYDROCHLORIDE
US Patents and Regulatory Information for CIMETIDINE HYDROCHLORIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dava Pharms Inc | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | INJECTABLE;INJECTION | 074428-001 | Apr 25, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Pharm Assoc | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | SOLUTION;ORAL | 075560-001 | Mar 15, 2000 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Hospira | CIMETIDINE HYDROCHLORIDE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | cimetidine hydrochloride | INJECTABLE;INJECTION | 074468-004 | Dec 29, 1994 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |